EXONDYS 51

eteplirsen · Sarepta Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for EXONDYS 51, covering 2015-10-06 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Compare Safety and Efficacy of High Doses of Eteplirsen in Participants With Duchenne Muscular Dystrophy (DMD) (MIS51ON) [Phase 3]

See pricing